Evolutia Bio
PrivateLast Round
Private Placement
Jul 18, 2024
Total Funding Raised
$31.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evolutia Bio operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Private Placement round in July 2024.
Evolutia Bio is a biotechnology company that develops proprietary biomanufacturing solutions, including custom enzymes, engineered strains, and processes for ingredient and industrial partners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Circular Economy
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolutia Bio Comparables
Compare Evolutia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conagen | 85% | |
| Lygos | 82% | |
| Manus Bio | 81% |
For institutional investors. Book with your work email.
Evolutia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 18, 2024 | ||||
| Convertible Debt | Oct 10, 2023 | ||||
| Follow-on Offering | Feb 19, 2021 | ||||
| Follow-on Offering | Oct 29, 2020 |
For institutional investors. Book with your work email.
Evolutia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canaccord Genuity | Follow-on Offering |
| ATB Capital Markets | Follow-on Offering |
| BMO Capital Markets | Follow-on Offering |
| Eight Capital | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Aug 21, 2026
Monthly visitors grew 39% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Evolutia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evolutia Bio's valuation, stock price, and market status.
Is Evolutia Bio a public or private company?
Evolutia Bio is a private company.
What is the current stock price of Evolutia Bio?
Evolutia Bio is a private company, so its shares have no public market price. Caplight tracks Evolutia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evolutia Bio worth (valuation)?
Valuation information for Evolutia Bio is not publicly available.
Can I buy Evolutia Bio stock?
Evolutia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evolutia Bio's last funding round?
Evolutia Bio's most recent funding round was Private Placement on July 18, 2024.
Who are the main investors in Evolutia Bio?
Key investors in Evolutia Bio include ATB Capital Markets, BMO Capital Markets, Eight Capital.
Will Evolutia Bio IPO soon?
No public IPO plans have been announced for Evolutia Bio.
How can I track Evolutia Bio secondary market activity?
Caplight tracks bids, offers, and trades in Evolutia Bio's shares on secondary markets.